Murine cytomegalovirus exploits olfaction to enter new hosts

mBio

Volumn 7, Issue 2, 2016, Pages

  Farrell, Helen E ^a   Lawler, Clara ^a   Tan, Cindy S E ^a   MacDonald, Kate ^a   Bruce, Kimberley ^a   Mach, Michael ^b   Davis Poynter, Nick ^a   Stevenson, Philip G ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HOST PATHOGEN INTERACTION; MALE; MICROBIAL COLONIZATION; MOUSE; NONHUMAN; NOSE INFECTION; OLFACTORY NERVE; PRIORITY JOURNAL; PUP (RODENT); SALIVARY GLAND; SMELLING; UPPER RESPIRATORY TRACT; VIRAL TROPISM; VIRUS ENTRY; VIRUS REPLICATION; VIRUS TRANSMISSION; WILD TYPE; ANIMAL; GENETICS; HUMAN; MUROMEGALOVIRUS; NOSE; ODOR; PHYSIOLOGY; RODENT DISEASE; VETERINARY; VIROLOGY;

ANIMALS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; MICE; MUROMEGALOVIRUS; NOSE; RODENT DISEASES; SALIVARY GLANDS; SMELL; VIRUS INTERNALIZATION;

EID: 84965125498     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00251-16     Document Type: Article

References (45)

1. Weller TH. 1971. The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. N Engl J Med 285:267–274. http://dx.doi.org/10.1056/NEJM197107292850507.
2. Lang DJ, Garruto RM, Gajdusek DC. 1977. Early acquisition of cytomegalovirus and Epstein-Barr virus antibody in several isolated Melanesian populations. Am J Epidemiol 105:480–487.
3. Schleiss MR. 2006. Acquisition of human cytomegalovirus infection in infants via breast milk: natural immunization or cause for concern? Rev Med Virol 16:73–82. http://dx.doi.org/10.1002/rmv.484.
4. Davey A, Eastman L, Hansraj P, Hemmings DG. 2011. Human cytomegalovirus is protected from inactivation by reversible binding to villous trophoblasts. Biol Reprod 85:198-207. http://dx.doi.org/10.1095/biolreprod.110.088567.
5. Omari TI, Davidson GP. 2003. Multipoint measurement of intragastric pH in healthy preterm infants. Arch Dis Child Fetal Neonatal Ed 88: F517–F520. http://dx.doi.org/10.1136/fn.88.6.F517.
6. de la Pena MG, Strelow L, Barry PA, Abel K. 2012. Use of specificpathogen- free (SPF) rhesus macaques to better model oral pediatric cytomegalovirus infection. J Med Primatol 41:225–229. http://dx.doi.org/10.1111/j.1600-0684.2012.00541.x.
7. Wu CA, Paveglio SA, Lingenheld EG, Zhu L, Lefrançois L, Puddington L. 2011. Transmission of murine cytomegalovirus in breast milk: a model of natural infection in neonates. J Virol 85:5115–5124. http://dx.doi.org/10.1128/JVI.01934-10.
8. Stahl FR, Keyser KA, Heller K, Bischoff Y, Halle S, Wagner K, Messerle M, Förster R. 2015. Mck2-dependent infection of alveolar macrophages promotes replication of MCMV in nodular inflammatory foci of the neonatal lung. Mucosal Immunol 8:57-67. http://dx.doi.org/10.1038/mi.2014.42.
9. Jordan MC. 1978. Interstitial pneumonia and subclinical infection after intranasal inoculation of murine cytomegalovirus. Infect Immun 21: 275–280.
10. Tan CS, Frederico B, Stevenson PG. 2014. Herpesvirus delivery to the murine respiratory tract. J Virol Methods 206:105–114. http://dx.doi.org/10.1016/j.jviromet.2014.06.003.
11. Xiang J, Zhang S, Nauwynck H. 2016. Infections of neonatal and adult mice with murine CMV HaNa1 strain upon oronasal inoculation: new insights in the pathogenesis of natural primaryCMVinfections. Virus Res 211:96–102. http://dx.doi.org/10.1016/j.virusres.2015.10.010.
12. Milho R, Smith CM, Marques S, Alenquer M, May JS, Gillet L, Gaspar M, Efstathiou S, Simas JP, Stevenson PG. 2009. In vivo imaging of murid herpesvirus-4 infection. J Gen Virol 90:21–32. http://dx.doi.org/10.1099/vir.0.006569-0.
13. Shivkumar M, Milho R, May JS, Nicoll MP, Efstathiou S, Stevenson PG. 2013. Herpes simplex virus 1 targets the murine olfactory neuroepithelium for host entry. J Virol 87:10477–10488. http://dx.doi.org/10.1128/JVI.01748-13.
14. Frederico B, Milho R, May JS, Gillet L, Stevenson PG. 2012. Myeloid infection links epithelial and B cell tropisms of murid herpesvirus-4. PLoS Pathog 8:e1002935. http://dx.doi.org/10.1371/journal.ppat.1002935.
15. Morawska L. 2006. Droplet fate in indoor environments, or can we prevent the spread of infection? Indoor Air 16:335–347. http://dx.doi.org/10.1111/j.1600-0668.2006.00432.x.
16. Luse SA, Smith MG. 1958. Electron microscopy of salivary gland viruses. J Exp Med 107:623–632. http://dx.doi.org/10.1084/jem.107.5.623.
17. Collins TM, Quirk MR, Jordan MC. 1994. Biphasic viremia and viral gene expression in leukocytes during acute cytomegalovirus infection of mice. J Virol 68:6305–6311.
18. Gordon S. 1999. Macrophage-restricted molecules: role in differentiation and activation. Immunol Lett 65:5–8. http://dx.doi.org/10.1016/S0165-2478(98)00116-3.
19. Fleming P, Davis-Poynter N, Degli-Esposti M, Densley E, Papadimitriou J, Shellam G, Farrell H. 1999. The murine cytomegalovirus chemokine homolog, m131/129, is a determinant of viral pathogenicity. J Virol 73:6800–6809.
20. Wagner FM, Brizic I, Prager A, Trsan T, Arapovic M, Lemmermann NA, Podlech J, Reddehase MJ, Lemnitzer F, Bosse JB, Gimpfl M, Marcinowski L, MacDonald M, Adler H, Koszinowski UH, Adler B. 2013. The viral chemokine MCK-2 of murine cytomegalovirus promotes infection as part of a gH/gL/MCK-2 complex. PLoS Pathog 9:e1003493. http://dx.doi.org/10.1371/journal.ppat.1003493.
21. Gambotto A, Dworacki G, Cicinnati V, Kenniston T, Steitz J, Tüting T, Robbins PD, DeLeo AB. 2000. Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kdrestricted CTL epitope. Gene Ther 7:2036-2040. http://dx.doi.org/10.1038/sj.gt.3301335.
22. Kudrycki K, Stein-Izsak C, Behn C, Grillo M, Akeson R, Margolis FL. 1993. Olf-1-binding site: characterization of an olfactory neuron-specific promoter motif. Mol Cell Biol 13:3002–3014. http://dx.doi.org/10.1128/MCB.13.5.3002.
23. Farrell HE, Davis-Poynter N, Bruce K, Lawler C, Dolken L, Mach M, Stevenson PG. 2015. Lymph node macrophages restrict murine cytomegalovirus dissemination. J Virol 89:7147–7158. http://dx.doi.org/10.1128/JVI.00480-15.
24. Harkema JR, Carey SA, Wagner JG. 2006. The nose revisited: a brief review of the comparative structure, function, and toxicologic pathology of the nasal epithelium. Toxicol Pathol 34:252–269. http://dx.doi.org/10.1080/01926230600713475.
25. Milho R, Frederico B, Efstathiou S, Stevenson PG. 2012. A heparandependent herpesvirus targets the olfactory neuroepithelium for host ent r y. PLoS Pathog 8:e1002986. http://dx.doi.org/10.1371/journal.ppat.1002986.
26. Hayashi K, Hayashi M, Jalkanen M, Firestone JH, Trelstad RL, Bernfield M. 1987. Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissues. A light and electron microscopic study. J Histochem Cytochem 35:1079-1088. http://dx.doi.org/10.1177/35.10.2957423.
27. Gillet L, May JS, Stevenson PG. 2009. In vivo importance of heparan sulfate-binding glycoproteins for murid herpesvirus-4 infection. J Gen Virol 90:602–613. http://dx.doi.org/10.1099/vir.0.005785-0.
28. Nahmias AJ, Kibrick S. 1964. Inhibitory effect of heparin on herpes simplex virus. J Bacteriol 87:1060–1066.
29. Compton T, Nowlin DM, Cooper NR. 1993. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology 193:834–841. http://dx.doi.org/10.1006/viro.1993.1192.
30. Gerna G, Lilleri D, Fornara C, Bruno F, Gabanti E, Cane I, Furione M, Revello MG. 2015. Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host. J Gen Virol 96:360-369. http://dx.doi.org/10.1099/vir.0.070441-0.
31. Tan CS, Stevenson PG. 2014. B cell response to herpesvirus infection of the olfactory neuroepithelium. J Virol 88:14030–14039. http://dx.doi.org/10.1128/JVI.02345-14.
32. Leclair JM, Zaia JA, Levin MJ, Congdon RG, Goldmann DA. 1980. Airborne transmission of chicken pox in a hospital. N Engl J Med 302: 450–453. http://dx.doi.org/10.1056/NEJM198002213020807.
33. Gillet L, Frederico B, Stevenson PG. 2015. Host entry by gammaherpesviruses- lessons from animal viruses? Curr Opin Virol 15:34–40. http://dx.doi.org/10.1016/j.coviro.2015.07.007.
34. François S, Vidick S, Sarlet M, Desmecht D, Drion P, Stevenson PG, Vanderplasschen A, Gillet L. 2013. Illumination of murine gammaherpesvirus-68 cycle reveals a sexual transmission route from females to males in laboratory mice. PLoS Pathog 9:e1003292. http://dx.doi.org/10.1371/journal.ppat.1003292.
35. Kozuch O, Reichel M, Lesso J, Remenová A, Labuda M, Lysý J, Mistríková J. 1993. Further isolation of murine herpesviruses from small mammals in southwestern Slovakia. Acta Virol 37:101–105.
36. Gaspar M, May JS, Sukla S, Frederico B, Gill MB, Smith CM, Belz GT, Stevenson PG. 2011. Murid herpesvirus-4 exploits dendritic cells to infect B cells. PLoS Pathog 7:e1002346. http://dx.doi.org/10.1371/journal.ppat.1002346.
37. Kalinke U, Bechmann I, Detje CN. 2011. Host strategies against virus entry via the olfactory system. Virulence 2:367–370. http://dx.doi.org/10.4161/viru.2.4.16138.
38. Corey L, Benedetti J, Critchlow C, Mertz G, Douglas J, Fife K, Fahnlander A, Remington ML, Winter C, Dragavon J. 1983. Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy. J Antimicrob Chemother 12(Suppl B): 79–88. http://dx.doi.org/10.1093/jac/12.suppl_B.79.
39. Tynell E, Aurelius E, Brandell A, Julander I, Wood M, Yao QY, Rickinson A, Akerlund B, Andersson J. 1996. Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study. J Infect Dis 174:324-331. http://dx.doi.org/10.1093/infdis/174.2.324.
40. McGeoch DJ, Cook S, Dolan A, Jamieson FE, Telford EA. 1995. Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J Mol Biol 247:443-458. http://dx.doi.org/10.1006/jmbi.1995.0152.
41. Yewdell JW, Hill AB. 2002. Viral interference with antigen presentation. Nat Immunol 3:1019–1025. http://dx.doi.org/10.1038/ni1102-1019.
42. Jordan S, Krause J, Prager A, Mitrovic M, Jonjic S, Koszinowski UH, Adler B. 2011. Virus progeny of murine cytomegalovirus bacterial artificial chromosome pSM3fr show reduced growth in salivary glands due to a fixed mutation of MCK-2. J Virol 85:10346-10353. http://dx.doi.org/10.1128/JVI.00545-11.
43. Sell S, Dietz M, Schneider A, Holtappels R, Mach M, Winkler TH. 2015. Control of murine cytomegalovirus infection by γδ T cells. PLoS Pathog 11:e1004481. http://dx.doi.org/10.1371/journal.ppat.1004481.
44. Kim JH, Lee SR, Li LH, Park HJ, Park JH, Lee KY, Kim MK, Shin BA, Choi SY. 2011. High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. PLoS One 6:e18556. http://dx.doi.org/10.1371/journal.pone.0018556.
45. Farrell HE, Lawler C, Oliveira MT, Davis-Poynter N, Stevenson PG. 2015. Alveolar macrophages are a prominent but nonessential target for murine cytomegalovirus infecting the lungs. J Virol 90:2756–2766. http://dx.doi.org/10.1128/JVI.02856-15.